Nguyen TT, Gates AT, Gutshall LL, Johnston VK, Gu B, Duffy KJ, Sarisky RT. . Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor. . Antimicrob Agents Chemother . 2003. 47(11) . 3525-3530. Find at Google Scholar.
Mo H, Lu L, Pilot-Matias T, Pithawalla R, Mondal R, Masse S, Dekhtyar T, Ng T, Koev G, Stoll V, Stew. Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor. Antimicrob Agents Chemother . 2005. 49(10). 4305-4314. Find at Google Scholar.
Tomei L, Altamura S, Bartholomew L, Bisbocci M, Bailey C, Bosserman M, Cellucci A, Forte E, Incitti . Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides. . J Virol. . 2004. 78(2) . 938-946. Find at Google Scholar.
Howe AY, Cheng H, Johann S, Mullen S, Chunduru SK, Young DC, Bard J, Chopra R, Krishnamurthy G, Mans. Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofur. Antimicrob Agents Chemother . 2008. 52(9) . 3327-3338. Find at Google Scholar.
Lu L, Mo H, Pilot-Matias TJ, Molla A. . Evolution of resistant M414T mutants among hepatitis C virus replicon cells treated with polymerase . Antimicrob Agents Chemother . 2007. 51(6) . 1889-1896 . Find at Google Scholar.
Thompson PA, Patel R, Showalter RE, Li C, Appleman JR, Steffy K. . In vitro studies demonostrate that combinations of antiviral agents that include HCV polymerase inhi. Hepatology . 2008. 48(1). S1164A. Find at Google Scholar.
Koev G, Mondal R, Beyer J, T. Reisch, S. Masse,W. Kati, D. Hutchinson, C. Flentge, J. Randolph, P. . Characterization of resistance mutations selected in vitro by the non-nucleoside HCV polymerase inhi. Annual Meeting of the European Association fo. 2009. 953. p. S346. Find at Google Scholar.
Bartels DJ, Sullivan JC, Zhang EZ, Tigges AM, Dorrian JL, De Meyer S, Takemoto D, Dondero E, Kwong A. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely. J Virol. . 2013. 87(3). 1544-1553. Find at Google Scholar.
Middleton T, He Y, Beyer J, Menon R, Klein C, Cohen D, Collins C. . Resistance profile of ABT-333 and relationship to viral load decrease in patients treated in combina. J. Hepatol. . 2010. 52. S296-S297. Find at Google Scholar.